These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 12073627

  • 1. [A case of secondary hyperparathyroidism with an ectopic intrathyroid gland successfully diagnosed and controlled by percutaneous ethanol injection therapy (PEIT)].
    Tanaka M, Itoh K, Matsushita K, Ogawa A, Hirayama H, Tsunoda N, Yoshizumi K, Naruse M, Nonoguchi H, Tomita K.
    Nihon Jinzo Gakkai Shi; 2002 May; 44(4):409-13. PubMed ID: 12073627
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of percutaneous ethanol injection therapy for secondary hyperparathyroidism in patients on hemodialysis as evaluated by parathyroid hormone levels according to K/DOQI guidelines.
    Tanaka M, Itoh K, Matsushita K, Matsushita K, Fukagawa M.
    Ther Apher Dial; 2005 Feb; 9(1):48-52. PubMed ID: 15828906
    [Abstract] [Full Text] [Related]

  • 3. Combination therapy of intravenous maxacalcitol and percutaneous ethanol injection therapy lowers serum parathyroid hormone level and calcium x phosphorus product in secondary hyperparathyroidism.
    Tanaka M, Itoh K, Matsushita K, Matsushita K, Fukagawa M.
    Nephron Clin Pract; 2006 Feb; 102(1):c1-7. PubMed ID: 16166800
    [Abstract] [Full Text] [Related]

  • 4. [A hemodialysis patient with secondary hyperparathyroidism in whom primary parathyroid adenoma was resected 27 years previously].
    Itoh K, Tanaka M, Matsushita K, Tominaga Y.
    Nihon Jinzo Gakkai Shi; 2003 Oct; 45(7):706-12. PubMed ID: 14631767
    [Abstract] [Full Text] [Related]

  • 5. Prognosis of parathyroid function after successful percutaneous ethanol injection therapy guided by color Doppler flow mapping in chronic dialysis patients.
    Kakuta T, Fukagawa M, Fujisaki T, Hida M, Suzuki H, Sakai H, Kurokawa K, Saito A.
    Am J Kidney Dis; 1999 Jun; 33(6):1091-9. PubMed ID: 10352197
    [Abstract] [Full Text] [Related]

  • 6. Percutaneous ethanol injection therapy in post-transplant patients with secondary hyperparathyroidism.
    Douthat WG, Orozco SE, Maino P, Cardozo G, de Arteaga J, de la Fuente J, Chiurchiu CR, Massari PU.
    Transpl Int; 2007 Dec; 20(12):1031-5. PubMed ID: 17883371
    [Abstract] [Full Text] [Related]

  • 7. [Ultrasonography-guided therapeutic procedures in the neck region].
    Brzac HT.
    Acta Med Croatica; 2009 Dec; 63 Suppl 3():21-7. PubMed ID: 20235370
    [Abstract] [Full Text] [Related]

  • 8. Magnetic resonance imaging (MRI) and technetium-99m-methoxyisonitrile (MIBI) scintigraphy to evaluate the abnormal parathyroid gland and PEIT efficacy for secondary hyperparathyroidism.
    Wada A, Sugihara M, Sugimura K, Kuroda H.
    Radiat Med; 1999 Dec; 17(4):275-82. PubMed ID: 10510900
    [Abstract] [Full Text] [Related]

  • 9. Parathyroid interventions for secondary hyperparathyroidism in hemodialyzed patients.
    Onoda N, Kashiwagi T, Nakamura T, Niitsu Y, Omata M, Kurihara S.
    Ther Apher Dial; 2005 Aug; 9 Suppl 1():S11-5. PubMed ID: 16109135
    [Abstract] [Full Text] [Related]

  • 10. [PEIT is the part of strategy for severe hyperparathyroidism in patients requiring hemodialysis].
    Uemura K, Kakuta T.
    Clin Calcium; 2004 Sep; 14(9):88-92. PubMed ID: 15577118
    [Abstract] [Full Text] [Related]

  • 11. [Hyperplasia and adenoma of the ectopic parathyroid gland].
    Zeze F, Itoh H, Ohsato K.
    Nihon Rinsho; 1995 Apr; 53(4):920-4. PubMed ID: 7752485
    [Abstract] [Full Text] [Related]

  • 12. Long-term (3 years) prognosis of parathyroid function in chronic dialysis patients after percutaneous ethanol injection therapy guided by colour Doppler ultrasonography.
    Tanaka R, Kakuta T, Fujisaki T, Tanaka S, Sakai H, Kurokawa K, Saito A.
    Nephrol Dial Transplant; 2003 Jun; 18 Suppl 3():iii58-61. PubMed ID: 12771303
    [Abstract] [Full Text] [Related]

  • 13. Intervention for recurrent secondary hyperparathyroidism from a residual parathyroid gland.
    Yumita S.
    Nephrol Dial Transplant; 2003 Jun; 18 Suppl 3():iii62-4. PubMed ID: 12771304
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of percutaneous ethanol injection therapy (PEIT) is related to the number of parathyroid glands in haemodialysis patients with secondary hyperparathyroidism.
    Koiwa F, Kakuta T, Tanaka R, Yumita S.
    Nephrol Dial Transplant; 2007 Feb; 22(2):522-8. PubMed ID: 17127701
    [Abstract] [Full Text] [Related]

  • 15. Hyperfunctioning intrathyroid parathyroid gland: a potential cause of failure in parathyroidectomy.
    Bahar G, Feinmesser R, Joshua BZ, Shpitzer T, Morgenstein S, Popovtzer A, Shvero J.
    Surgery; 2006 Jun; 139(6):821-6. PubMed ID: 16782440
    [Abstract] [Full Text] [Related]

  • 16. A case of parathyroid adenoma adjacent to the thoracic spine in a hemodialysis patient.
    Nakai K, Fujii H, Maeno K, Nishida K, Kobayashi A, Shin J, Hara S, Nishi S.
    Clin Nephrol; 2014 Jan; 81(1):52-7. PubMed ID: 22854163
    [Abstract] [Full Text] [Related]

  • 17. Surgical treatment of mediastinal parathyroid adenoma.
    Maraković J, Biocina B, Sutlić Z, Rudez I, Kolovrat M, Barić D, Husedzinović I, Rupcić V.
    Acta Med Croatica; 2002 Jan; 56(2):65-8. PubMed ID: 12596627
    [Abstract] [Full Text] [Related]

  • 18. Clinical profile and outcome of primary hyperparathyroidism accompanied by chronic renal failure.
    Mizumoto D, Watanabe Y, Fukuzawa Y, Aoi N, Yamazaki C.
    Clin Nephrol; 1994 Nov; 42(5):315-21. PubMed ID: 7851033
    [Abstract] [Full Text] [Related]

  • 19. Effects of percutaneous ethanol injection therapy on subsequent parathyroidectomy.
    Chen HH, Hsu MT, Wu CJ, Chen YW, Yang TL.
    Am J Surg; 2008 Aug; 196(2):155-9. PubMed ID: 18513687
    [Abstract] [Full Text] [Related]

  • 20. Percutaneous ethanol injection therapy: a surgery-sparing treatment for primary hyperparathyroidism.
    Stratigis S, Stylianou K, Mamalaki E, Perakis K, Vardaki E, Tzenakis N, Katsipi I, Papavasiliou S, Yarmenitis S, Kyriazis J, Daphnis E.
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):542-8. PubMed ID: 18331604
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.